Zynex Hires Director of Business Development

Zynex Inc., a Lone Tree, Colo.-based medical technology company specializing in non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics and compound pharmacy, announced the hiring of Steve Siefring as director of business development. Seifring will be responsible for driving sales activities in the electrotherapy and compound pharmacy business, reporting to Robert Bird, vice president of sales in the United States.

Siefring has over 20 years of healthcare related sales and business development experience, specifically in the electrotherapy market space, with approximately 12 years at Empi Inc. Zynex’s main competitor, Empi is a DJO Global company that makes electrical stimulation and other orthopedic products used for pain management and orthopedic rehabilitation. Siefring also previously held executive sales positions with MicroAire Surgical Instruments and Genzyme Surgical.

“We are very excited to have Steve Siefring join our team,” said CEO Thomas Sandgaard. “Steve’s electrotherapy and sales background is truly a great match for us at this time, as he spent approximately 12 years with our biggest competitor, Empi Inc. Steve will initially focus on expanding our electrotherapy and compound pain cream sales channel. We believe our efforts to re-position the company for growth over the past several quarters are beginning to bear fruit, and the addition of Siefring will be a another catalyst to help us drive opportunities across to this strategically important business segment.”

Siefring holds a B.S. degree in Marketing from Ohio State University.

Zynex Medical designs, manufactures and sells electrotherapy medical devices used for pain management and rehabilitation. The company also markets a proprietary device, Neuromove, designed to aid in the recovery of stroke and spinal cord injury patients.